ArticleArthritis research & therapy2011

Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome.

Roy A Fava et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.